Media

The Biotechnology Industry Organization (BIO) today announced that it will showcase a series of unique sessions at this year’s Livestock Biotech Summit...
Sessions to focus on the FDA Breakthrough Therapy Designation Process, IPO Market, and BioCentury’s Back to School issue

Press Releases

Feb 29 2000
WASHINGTON, D.C. (February 29, 2000) -- The Biotechnology Industry Organization (BIO) has placed on its website (www.bio.org) a BIO 2000 News Room to provide...
Feb 25 2000
WASHINGTON, D.C. (February 25, 2000) Genomics has captured the attention of Wall Street investors and the imagination of others worldwide as researchers near...
Feb 23 2000
WASHINGTON, D.C. (February 23, 2000) The BiotechnologyIndustry Organization (BIO) issued the following statement in response to the bill introduced by U.S....
Feb 17 2000
EXECUTIVE SUMMARY BIO represents over 850 biotechnology companies, academic institutions, state biotechnology centers, and related organizations in 46 states...
Feb 14 2000
WASHINGTON, D.C. (February 14, 2000) - Christopher Reeve, paralyzed five years ago after a fall during an equestrian competition, will discuss his life and...
Feb 10 2000
WASHINGTON, D.C. (February 11, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a...
Feb 8 2000
WASHINGTON, D.C. (February 8, 2000) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today on...
Jan 27 2000
WASHINGTON, D.C. (Jan. 27, 2000) Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement on Medicare...
Jan 21 2000
WASHINGTON, D.C. (Jan. 21, 1999) Not too long ago, the idea of treating the root causes of diseases was just that, an idea. And so was the prospect of feeding...